{"domain":"nabsys.com","status":"valid","tier":"listed","authority":46,"verified":false,"title":"Nabsys","summary":"Nabsys is a genomics technology company advancing structural variant (SV) detection through proprietary Electronic Genome Mapping (EGM). Implemented on the OhmX™ Platform, EGM integrates precision electronics, nanofluidics, and computational biology to deliver high-resolution, cost-effective whole-genome SV analysis for cytogenetics, molecular genetics, cancer research, rare disease research, and cell & gene therapy. Nabsys is headquartered at 60 Clifford Street, Providence, RI, and is majority-","country":"US","country_source":"ip","publisher_country":null,"publisher_country_source":null,"hosting_country":"US","llms_txt":"https://www.nabsys.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-24T04:00:19.363Z","agent_terms":null,"categories":["science-research","healthcare"],"capabilities":[],"inferred_tags":["genomics","structural variant detection","electronic genome mapping","ohmx platform","whole-genome analysis"],"audience":"business","agent_uses":["read_docs","contact_support"],"language":"en","platform_generated":false,"agent_summary":"Nabsys: genomics company whose OhmX Platform uses Electronic Genome Mapping for whole-genome structural variant analysis; includes product specs, FAQs and conta","llms_txt_cached":"https://agentwebmap.com/v1/domain/nabsys.com/llms.txt","agentic":"documentation","section_keys":["about","applications","core-pages","learn-technology","legal","resources"],"section_partial":false,"section_indexed_at":"2026-10-24T04:00:31.729Z"}